Search Results 81-90 of 16756 for CLL
-
... chronic lymphocytic leukemia (CLL). It is composed of a patient survey (n=250), a physician survey (n=100), and a practice survey completed by each site ...
-
Diagnosis of chronic lymphocytic leukemia (CLL) per diagnostic criteria and relapsed or refractory CLL per the iwCLL guidelines. Previously treated with 1-3 ...
-
Lindsey Roeker, M.D., is a board-certified hematologist / oncologist and clinical researcher focusing on chronic lymphocytic leukemia (CLL) and Richter's ...
-
This phase I trial studies the side effects and best dose of romidepsin in treating patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with ...
-
A Study to Evaluate Daratumumab and Ibrutinib to Treat Relapsed / Refractory Chronic Lymphocytic Leukemia Treatment (DIRECT). Print details. Share; Facebook ...
-
... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy control (HC) donors. Participation eligibility. Participant eligibility includes age ...
-
... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...
-
Dr. Cerhan's NHL & CLL case-control study at Mayo Clinic tests hypotheses about the etiology of non-Hodgkin lymphoma and chronic lymphocytic leukemia.
-
... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...
-
... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...